Skip to main content
Clinical Trials/TCTR20220113002
TCTR20220113002
Completed
Not Applicable

Study of proteomics for identification of novel prognostic biomarkers in patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resection

Ratchadapisek Research Funds0 sites115 target enrollmentJanuary 13, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hepatocellular carcinoma and Intrahepatic cholangiocarcinoma
Sponsor
Ratchadapisek Research Funds
Enrollment
115
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 13, 2022
End Date
November 23, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Ratchadapisek Research Funds

Eligibility Criteria

Inclusion Criteria

  • patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resection from King Chulalongkorn Memorial Hospital

Exclusion Criteria

  • 1\. Smoking
  • 2\. Congenital disease
  • 3\. A patient who had a bowel resection

Outcomes

Primary Outcomes

Not specified

Similar Trials